Michael Weller

Affiliated with

Research Area

Biography

Michael Weller has not added Biography.
If you are Michael Weller and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 8	2016

Other Publications

Article	Year
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. The Lancet. Oncology\| PubMed ID: 22578793	2012
Optimal management of elderly patients with glioblastoma. Cancer treatment reviews\| PubMed ID: 22722053	2013
CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells. The EMBO journal\| PubMed ID: 21857646	2011
Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial. Acta neurochirurgica\| PubMed ID: 21909835	2012
2-Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size. International journal of cancer\| PubMed ID: 21913188	2012
Geriatric neuro-oncology: from mythology to biology. Current opinion in neurology\| PubMed ID: 21968549	2011
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature\| PubMed ID: 21976023	2011
Clinical trials in neuro-oncology: one step forward, two steps back? Current opinion in neurology\| PubMed ID: 21986679	2011
Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 22080438	2012
Predictive impact of MGMT promoter methylation in glioblastoma of the elderly. International journal of cancer\| PubMed ID: 22139906	2012
Non-invasive monitoring of immunization progress in mice via IgG from feces. In vivo (Athens, Greece)\| PubMed ID: 22210717	2012
Immunology of brain tumors. Handbook of clinical neurology\| PubMed ID: 22230434	2012
Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of t... Acta neuropathologica\| PubMed ID: 22249618	2012
Individualized targeted therapy for glioblastoma: fact or fiction? Cancer journal (Sudbury, Mass.)\| PubMed ID: 22290256	2012
Extremely sensitive and selective antibodies against the explosive 2,4,6-trinitrotoluene by rational design of a structurally optimized hapten. Journal of molecular recognition : JMR\| PubMed ID: 22290770	2012
Monitoring the glioma tropism of bone marrow-derived progenitor cells by 2-photon laser scanning microscopy and positron emission tomography. Neuro-oncology\| PubMed ID: 22298526	2012
Sustained efficacy of natalizumab in the treatment of relapsing-remitting multiple sclerosis independent of disease activity and disability at baseline: real-life data from a Swiss cohort. Clinical neuropharmacology\| PubMed ID: 22318192	2012
Autoimmune myasthenia gravis after sternal fracture. Case reports in neurology\| PubMed ID: 22393321	2012
Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma? Expert opinion on investigational drugs\| PubMed ID: 22413865	2012
Clinical implications of molecular neuropathology and biomarkers for malignant glioma. Current neurology and neuroscience reports\| PubMed ID: 22427102	2012
Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma. PloS one\| PubMed ID: 22428052	2012
Antiepileptic drugs and vitamin B6 plasma levels in adult patients. Epilepsy research\| PubMed ID: 22464176	2012
Comparative evaluation of the drug interaction screening programs MediQ and ID PHARMA CHECK in neurological inpatients. Pharmacoepidemiology and drug safety\| PubMed ID: 22517594	2012
More on the immune privilege of glioblastoma. Neuro-oncology\| PubMed ID: 22539528	2012
Phase 2 trial design in neuro-oncology revisited: a report from the RANO group. The lancet oncology\| PubMed ID: 22554547	2012
Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells. Journal of neurochemistry\| PubMed ID: 22564186	2012
Pathogenesis and management of primary CNS lymphoma. Expert review of anticancer therapy\| PubMed ID: 22594897	2012
Immunoassays as high-throughput tools: monitoring spatial and temporal variations of carbamazepine, caffeine and cetirizine in surface and wastewaters. Chemosphere\| PubMed ID: 22682895	2012
HLA-E contributes to an immune-inhibitory phenotype of glioblastoma stem-like cells. Journal of neuroimmunology\| PubMed ID: 22688424	2012
Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness? Journal of sleep research\| PubMed ID: 22747735	2012
Drug-related problems and factors influencing acceptance of clinical pharmacologists` alerts in a large cohort of neurology inpatients. Swiss medical weekly\| PubMed ID: 22777799	2012
Comparison of the fragmentation behavior of differentially metal-coded affinity tag (MeCAT)-labeled peptides. Journal of mass spectrometry : JMS\| PubMed ID: 22791256	2012
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for... Acta neuropathologica\| PubMed ID: 22810491	2012
Antiangiogenic treatment for multiple CNS hemangioblastomas. Onkologie\| PubMed ID: 22846977	2012
Microglia: a novel treatment target in gliomas. Neuro-oncology\| PubMed ID: 22851682	2012
CT-only planning for Gamma Knife radiosurgery in the treatment of trigeminal neuralgia: methodology and outcomes from a single institution. Journal of medical imaging and radiation oncology\| PubMed ID: 22883661	2012
Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial. Neurology\| PubMed ID: 22895585	2012
Epilepsy meets cancer: when, why, and what to do about it? The Lancet. Oncology\| PubMed ID: 22935237	2012
Surgery for primary CNS lymphoma? Challenging a paradigm. Neuro-oncology\| PubMed ID: 22984018	2012
Epidermal growth factor receptor: a re-emerging target in glioblastoma. Current opinion in neurology\| PubMed ID: 23007009	2012
Deletion of the ageing gene p66Shc reduces early stroke size following ischaemia/reperfusion brain injury. European heart journal\| PubMed ID: 23008506	2012
A unifying review of bioassay-guided fractionation, effect-directed analysis and related techniques. Sensors (Basel, Switzerland)\| PubMed ID: 23012539	2012
Prime time for molecular marker diagnostics in neuro-oncology. Current opinion in neurology\| PubMed ID: 23041956	2012
Angiogenesis inhibition: quo vadis? Neuro-oncology\| PubMed ID: 23095501	2012
Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice. Neuro-oncology\| PubMed ID: 23095825	2012
Standards of care for treatment of recurrent glioblastoma--are we there yet? Neuro-oncology\| PubMed ID: 23136223	2013
Bevacizumab alone or in combination with irinotecan in recurrent WHO grade II and grade III gliomas. European neurology\| PubMed ID: 23182901	2013
Expression of integrins αvβ3 and αvβ5 and their ligands in primary and secondary central nervous system neoplasms. Histology and histopathology\| PubMed ID: 23238957	2013
The costs of disorders of the brain in Switzerland: an update from the European Brain Council Study for 2010. Swiss medical weekly\| PubMed ID: 23297120	2013
Integrin control of the transforming growth factor-β pathway in glioblastoma. Brain : a journal of neurology\| PubMed ID: 23378223	2013
Assessing the MGMT status in glioblastoma: one step forward, two steps back? Neuro-oncology\| PubMed ID: 23430603	2013
Selective, sensitive, and rapid analysis with lateral-flow assays based on antibody-gated dye-delivery systems: the example of triacetone triperoxide. Chemistry (Weinheim an der Bergstrasse, Germany)\| PubMed ID: 23447084	2013
High-dose praziquantel therapy for cerebral sparganosis. Journal of neurology\| PubMed ID: 23546305	2013
Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective. Neuro-oncology\| PubMed ID: 23595628	2013
αv-Integrin isoform expression in primary human tumors and brain metastases. International journal of cancer\| PubMed ID: 23661241	2013
Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway. PloS one\| PubMed ID: 23667632	2013
Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach. Acta neuropathologica\| PubMed ID: 23689616	2013
The time of maximum post-ischemic hyperperfusion indicates infarct growth following transient experimental ischemia. PloS one\| PubMed ID: 23741488	2013
Primary central nervous system tumors: pathogenesis and therapy. Archives of neurology\| PubMed ID: 23754022	2012
Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs. Nature medicine\| PubMed ID: 23770692	2013
Are we ready for a randomized trial of valproic acid in newly diagnosed glioblastoma? Neuro-oncology\| PubMed ID: 23788268	2013
The cascade radical cyclisation approach to prenylated alkaloids: synthesis of stephacidin A and notoamide B. Organic & biomolecular chemistry\| PubMed ID: 23797367	2013
End-of-life caregivers' perception of medical and psychological support during the final weeks of glioma patients: a questionnaire-based survey. Neuro-oncology\| PubMed ID: 23814266	2013
Angiogenesis inhibition for glioblastoma at the edge: beyond AVAGlio and RTOG 0825. Neuro-oncology\| PubMed ID: 23864129	2013
JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment. Annals of neurology\| PubMed ID: 23868420	2013
Molecular neuro-oncology in clinical practice: a new horizon. The Lancet. Oncology\| PubMed ID: 23896276	2013
ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis. Acta neuropathologica\| PubMed ID: 23904111	2013
Anaplastic oligodendroglioma: a new treatment paradigm and current controversies. Current treatment options in oncology\| PubMed ID: 23907441	2013
Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 23918605	2013
APO010, a synthetic hexameric CD95 ligand, induces death of human glioblastoma stem-like cells. Anticancer research\| PubMed ID: 24023281	2013
Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation. Journal of neuropathology and experimental neurology\| PubMed ID: 24042196	2013
Immunological challenges for peptide-based immunotherapy in glioblastoma. Cancer treatment reviews\| PubMed ID: 24064197	2014
Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation. Neurology\| PubMed ID: 24068788	2013
Invasion patterns in brain metastases of solid cancers. Neuro-oncology\| PubMed ID: 24084410	2013
EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma. Cancer cell\| PubMed ID: 24135280	2013
Tumor-associated edema in brain cancer patients: pathogenesis and management. Expert review of anticancer therapy\| PubMed ID: 24152171	2013
Malignant astrocytoma in elderly patients: where do we stand? Current opinion in neurology\| PubMed ID: 24152817	2013
Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system. Acta neuropathologica\| PubMed ID: 24154961	2013
Immunoassays and biosensors for the detection of cyanobacterial toxins in water. Sensors (Basel, Switzerland)\| PubMed ID: 24196435	2013
Single-institution retrospective series of gamma knife radiosurgery in the treatment of multiple sclerosis-related trigeminal neuralgia: factors that predict efficacy. Stereotactic and functional neurosurgery\| PubMed ID: 24217153	2014
Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell-mediated glioma rejection. The Journal of experimental medicine\| PubMed ID: 24277150	2013
The legend of cytomegalovirus and glioblastoma lives on. Neuro-oncology\| PubMed ID: 24311642	2014
Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study. Neuro-oncology\| PubMed ID: 24311644	2014
A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cells. Neuro-oncology\| PubMed ID: 24327582	2014
Treatment of primary CNS lymphoma. Current treatment options in neurology\| PubMed ID: 24343307	2014
Thymosin β 4 gene silencing decreases stemness and invasiveness in glioblastoma. Brain : a journal of neurology\| PubMed ID: 24355709	2014
mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 24367102	2014
Genetic variants of homocysteine metabolism and multiple sclerosis: a case-control study. Neuroscience letters\| PubMed ID: 24412677	2014
Neuro-oncology in 2013: improving outcome in newly diagnosed malignant glioma. Nature reviews. Neurology\| PubMed ID: 24419684	2014
Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression. Journal of neuro-oncology\| PubMed ID: 24442484	2014
Amyotrophic lateral sclerosis after embolization of cerebral arterioveneous malformations. Journal of neurology\| PubMed ID: 24509642	2014
Interferon-β induces loss of spherogenicity and overcomes therapy resistance of glioblastoma stem cells. Molecular cancer therapeutics\| PubMed ID: 24526161	2014
Clinical reasoning: a 30-year-old woman with recurrent seizures and a cerebral lesion progressing over 2 decades. Neurology\| PubMed ID: 24536067	2014
Etoposide/carboplatin chemotherapy for the treatment of metastatic myxomatous cerebral aneurysms. Journal of neurology\| PubMed ID: 24603973	2014
Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy. International journal of cancer\| PubMed ID: 24614983	2014
Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling. International journal of cancer\| PubMed ID: 24615357	2014
Genomic profiling reveals distinctive molecular relapse patterns in IDH1/2 wild-type glioblastoma. Genes, chromosomes & cancer\| PubMed ID: 24706357	2014
ERGO: a pilot study of ketogenic diet in recurrent glioblastoma. International journal of oncology\| PubMed ID: 24728273	2014
Neuropathological characteristics of progression after prolonged response to bevacizumab in multifocal hemangioblastoma. Oncology research and treatment\| PubMed ID: 24732646	2014
Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients. Journal of neuro-oncology\| PubMed ID: 24736829	2014
Hypoxia enhances the antiglioma cytotoxicity of B10, a glycosylated derivative of betulinic acid. PloS one\| PubMed ID: 24743710	2014
Questions regarding the optimal use of bevacizumab in glioblastoma: a moving target. Neuro-oncology\| PubMed ID: 24826844	2014
Addition of lomustine for bevacizumab-refractory recurrent glioblastoma. Acta oncologica (Stockholm, Sweden)\| PubMed ID: 24862539	2014
MGMT testing--the challenges for biomarker-based glioma treatment. Nature reviews. Neurology\| PubMed ID: 24912512	2014
3-Nitropropionic acid-induced ischemia tolerance in the rat brain is mediated by reduced metabolic activity and cerebral blood flow. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism\| PubMed ID: 24938399	2014
The vanishing role of whole brain radiotherapy for primary central nervous system lymphoma. Neuro-oncology\| PubMed ID: 24958097	2014
Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity? Journal of neurochemistry\| PubMed ID: 24976529	2014
Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma. Acta neuropathologica\| PubMed ID: 25008768	2014
Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial. Neuro-oncology\| PubMed ID: 25028501	2014
Shaping the glioma immune microenvironment through tryptophan metabolism. CNS oncology\| PubMed ID: 25054303	2012
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. The Lancet. Oncology\| PubMed ID: 25079102	2014
Primary central nervous system lymphoma in the elderly. Oncology research and treatment\| PubMed ID: 25138296	2014
αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer. Clinical & experimental metastasis\| PubMed ID: 25150423	2014
Letter to the Editor: "The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline" [J Neurooncol 2014; 118:435-460]... Journal of neuro-oncology\| PubMed ID: 25151508	2014
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-l... The Lancet. Oncology\| PubMed ID: 25163906	2014
Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma. Neuro-oncology\| PubMed ID: 25165192	2015
Prognostic impact of intraocular involvement in primary CNS lymphoma: experience from the G-PCNSL-SG1 trial. Annals of hematology\| PubMed ID: 25217230	2015
Reciprocal modulation of Aβ42 aggregation by copper and homocysteine. Frontiers in aging neuroscience\| PubMed ID: 25249976	2014
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape. Oncotarget\| PubMed ID: 25277195	2014
How stemlike are sphere cultures from long-term cancer cell lines? Lessons from mouse glioma models. Journal of neuropathology and experimental neurology\| PubMed ID: 25289892	2014
Dynamic 18F-FET PET in suspected WHO grade II gliomas defines distinct biological subgroups with different clinical courses. International journal of cancer\| PubMed ID: 25311315	2015
Challenges to targeting epidermal growth factor receptor in glioblastoma: escape mechanisms and combinatorial treatment strategies. Neuro-oncology\| PubMed ID: 25342600	2014
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma. Neuro-oncology\| PubMed ID: 25355681	2015
Antiangiogenic therapy for glioblastoma: current status and future prospects. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 25398844	2014
Clinically isolated neurosarcoidosis: a recommended diagnostic path. European neurology\| PubMed ID: 25401278	2015
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma a... Acta neuropathologica\| PubMed ID: 25427834	2015
Does cilengitide deserve another chance?-Authors' reply. The Lancet. Oncology\| PubMed ID: 25456377	2014
Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 25534293	2015
Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM. Neurology\| PubMed ID: 25609769	2015
Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma. Genome biology\| PubMed ID: 25622821	2015
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 25655102	2015
Adjuvant versus neoadjuvant androgen deprivation with radiotherapy for prostate cancer: does sequencing matter? Clinical genitourinary cancer\| PubMed ID: 25660127	2015
Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma. Neuro-oncology\| PubMed ID: 25665807	2015
Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma. Neurology\| PubMed ID: 25716362	2015
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups. Acta neuropathologica\| PubMed ID: 25783747	2015
Efficacy of Surgery and Further Treatment of Progressive Glioblastoma. World neurosurgery\| PubMed ID: 25797075	2015
Prognostic impact of B-cell lymphoma 6 in primary CNS lymphoma. Neuro-oncology\| PubMed ID: 25817328	2015
Transforming growth factor-β pathway activity in glioblastoma. Oncotarget\| PubMed ID: 25849941	2015
[Neuro-oncology]. Der Nervenarzt\| PubMed ID: 25986916	2015
Malignant optic glioma - the spectrum of disease in a case series. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie\| PubMed ID: 26004076	2015
Program director and chief resident perspectives on the educational environment of US radiation oncology programs. Practical radiation oncology\| PubMed ID: 27523441	2016
The management of lomustine overdose in malignant glioma patients. Neuro-oncology practice\| PubMed ID: 26034630	2014
Corticosteroid use in neuro-oncology: an update. Neuro-oncology practice\| PubMed ID: 26034636	2015
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Acta neuropathologica\| PubMed ID: 26087904	2015
Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition. Oncotarget\| PubMed ID: 26090865	2015
Brain metastasis research: a late awakening. Chinese clinical oncology\| PubMed ID: 26112803	2015
Management of neoplastic meningitis. Chinese clinical oncology\| PubMed ID: 26112812	2015
Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. The Lancet. Oncology\| PubMed ID: 26149884	2015
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. Neuro-oncology\| PubMed ID: 26250565	2015
Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma. Neuro-oncology\| PubMed ID: 26354929	2016
Management of diffusely infiltrating glioma in the elderly. Current opinion in oncology\| PubMed ID: 26397765	2015
Immunotherapy for glioblastoma: concepts and challenges. Current opinion in neurology\| PubMed ID: 26402401	2015
Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells. PloS one\| PubMed ID: 26441059	2015
Development of highly sensitive and selective antibodies for the detection of the explosive pentaerythritol tetranitrate (PETN) by bioisosteric replacement. Journal of molecular recognition : JMR\| PubMed ID: 26463875	2016
Computer-assisted quantification of motile and invasive capabilities of cancer cells. Scientific reports\| PubMed ID: 26486848	2015
Gliomatosis cerebri: no evidence for a separate brain tumor entity. Acta neuropathologica\| PubMed ID: 26493382	2016
Carboplatin and Etoposide in Heavily Pretreated Patients with Progressive High-Grade Glioma. Chemotherapy\| PubMed ID: 26496463	2014
Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma? Clinical neuropathology\| PubMed ID: 26501438	2015
Neurology--the next 10 years. Nature reviews. Neurology\| PubMed ID: 26503922	2015
Introduction. Neuro-oncology\| PubMed ID: 26516220	2015
Dedication: Andrew T. Parsa. Neuro-oncology\| PubMed ID: 26516222	2015
Immunosuppressive mechanisms in glioblastoma. Neuro-oncology\| PubMed ID: 26516226	2015
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. The Lancet. Oncology\| PubMed ID: 26545842	2015
Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas. Neuro-oncology\| PubMed ID: 26578622	2016
New insights into acquired temozolomide resistance in glioblastoma? Brain : a journal of neurology\| PubMed ID: 26598490	2015
Predicting outcome of epilepsy after meningioma resection. Neuro-oncology\| PubMed ID: 26683139	2016
Control of glioma cell migration and invasiveness by GDF-15. Oncotarget\| PubMed ID: 26741507	2016
Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entity. Acta neuropathologica\| PubMed ID: 26744347	2016
Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern. Multiple sclerosis (Houndmills, Basingstoke, England)\| PubMed ID: 26762672	2016
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 26786929	2016
Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial. Neuro-oncology\| PubMed ID: 26823503	2016
Therapeutic options in recurrent glioblastoma--An update. Critical reviews in oncology/hematology\| PubMed ID: 26830009	2016
68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate? Neuro-oncology\| PubMed ID: 26865086	2016
MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM. Oncotarget\| PubMed ID: 26887050	2016
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome. Oncotarget\| PubMed ID: 26918452	2016
Glioblastoma. Handbook of clinical neurology\| PubMed ID: 26948367	2016
Altered intraoperative cerebrovascular reactivity in brain areas of high-grade glioma recurrence. Magnetic resonance imaging\| PubMed ID: 26968146	2016
[Gliomas – What I Have to Know in ten Questions]. Praxis\| PubMed ID: 26980684	2016
Therapy for Secondary CNS Involvement in Malignant Lymphomas: No Standard Yet! Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 27001566	2016
Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo. Neuro-oncology\| PubMed ID: 27009237	2016
Quality Issues of Research Antibodies. Analytical chemistry insights\| PubMed ID: 27013861	2016
Corticosteroids compromise survival in glioblastoma. Brain : a journal of neurology\| PubMed ID: 27020328	2016
Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectives. Expert opinion on pharmacotherapy\| PubMed ID: 27052640	2016
Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009. Cancer\| PubMed ID: 27088883	2016
Somatostatin-receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake. Neuro-oncology\| PubMed ID: 27106404	2016
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro-oncology\| PubMed ID: 27106405	2016
Chemotherapy for intracranial ependymoma in adults. BMC cancer\| PubMed ID: 27108407	2016
Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082). Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 27143690	2016
Glioma. Nature reviews. Disease primers\| PubMed ID: 27188790	2015
Gene-Tailored Treatments for Brain Disorders: Challenges and Opportunities. Public health genomics\| PubMed ID: 27238144	2016
Current State of Immune-Based Therapies for Glioblastoma. American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting\| PubMed ID: 27249715	2016
Immunotherapy of Brain Cancer. Oncology research and treatment\| PubMed ID: 27260656	2016
Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cells. Oncotarget\| PubMed ID: 27270311	2016
Limited role for transforming growth factor-β pathway activation-mediated escape from VEGF inhibition in murine glioma models. Neuro-oncology\| PubMed ID: 27286797	2016
Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma. Journal of neuro-oncology\| PubMed ID: 27294357	2016
Reply to F. Felix et al and M.F. Fay et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 27298403	2016
Boswellic acid activity against glioblastoma stem-like cells. Oncology letters\| PubMed ID: 27313764	2016
Interleukin-33 in human gliomas: Expression and prognostic significance. Oncology letters\| PubMed ID: 27347163	2016
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide. Neuro-oncology\| PubMed ID: 27370396	2016
The Role of Molecular Diagnostics in the Management of Patients with Gliomas. Current treatment options in oncology\| PubMed ID: 27501915	2016